MDGuidelines Launches Duration Analyzer TM
- Futures muted after S&P 500, Dow hit record closing highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Dollar heads for second week of losses as yields decline
- Morgan Stanley (MS) Tops Q1 EPS by 52c
- Apple (AAPL) May Scrap iPhone Mini Next Year, New Lineup to Focus on Camera Quality, Says Top Analyst
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
WESTMINSTER, Colo.--(BUSINESS WIRE)-- MDGuidelines®, the leading evidence-based guidelines for disability and workers’ compensation, today released the MDGuidelines Duration AnalyzerTM, a new tool for benchmarking claims performance. Duration Analyzer allows comparisons between short-term disability or workers’ compensation injury/illness durations to MDGuidelines’ population and physiological duration benchmarks. The tool provides advanced reporting and integrates diagnostic-level detail with the benchmark information.
“This new tool is designed for anyone who wants to compare claims data to gold-standard duration benchmarks,” said Joe Guerriero, SVP of MDGuidelines. “If you’re responsible for disability claims optimization, Duration Analyzer can help you identify areas for improvement and cost savings by allowing you to compare your population to our national dataset.” Data analysts, data scientists, claims professionals, employee health managers, and healthcare administrators, among other professionals, are expected to find value in the tool.
How Duration Analyzer Works
Duration Analyzer draws on statistics from MDGuidelines’ proprietary population database which includes estimates of typical disability durations for more than 20,000 diagnoses. Based on more than 18 million claims, the population database offers a robust set of data representing national demographics, industries, psychosocial factors, and benefit structures. The database includes real-world claims that are both managed and non-managed. Duration Analyzer also leverages the expertise of the MDGuidelines Medical Advisory Board, a panel of physicians with clinical specialties in fields such as internal medicine, occupational medicine, psychiatry, orthopedics, rehabilitation, and more. The Board is responsible for creating MDGuidelines’ disability duration estimates, based on physiological healing times, and informed by data analytics and medical expertise.
Duration Analyzer is available to all MDGuidelines subscribers at no additional cost. A version of the tool with limited features is available, free to all, at www.mdguidelines.com.
MDGuidelines is the industry’s leading solution for total health management and workplace productivity. MDGuidelines features the world’s most trusted disability duration estimates and evidence-based Clinical Practice Guidelines from the American College of Occupational and Environmental Medicine (ACOEM), and is used around the world by healthcare payers, providers, and employers to help patients return to activity quickly and safely. MDGuidelines is a proven approach to managing and measuring the impact of evidence-based care across entire populations. To learn more, follow MDGuidelines on LinkedIn and Twitter.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coinsquare Announces Closing of Strategic Investment by Mogo
- Modernizing Medicine Acquires TRAKnet to Accelerate Innovation in Podiatry
- Is a Bitcoin ETF Inevitable, and What to do about it? (NYSE: SQ) (NASDAQ: OSTK) (OTC US: ISWH) (OTC US: HVBTF)
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!